August 13: Roberts told reporters (including Harris) that tests did not find any structural damage in Stewart’s shoulder. Instead, the skipper described the injury as simply “wear and tear.” Stewart has received an injection and will be shut down for at least the next week. However, Roberts is hopeful the veteran will be back not long after, optimistically suggesting he could return in a few weeks’ time.
August 12: The Dodgers are placing reliever Brock Stewart on the injured list with shoulder inflammation, manager Dave Roberts told reporters (including Fabian Ardaya of The Athletic). He will be replaced on the active roster with Edgardo Henriquez (per Jack Harris of the Los Angeles Times). Ardaya reported earlier today that Henriquez had joined the team in Anaheim.
Roberts said Stewart first felt the soreness in his shoulder four days ago (per Harris), which would mean before his outing against the Blue Jays on Saturday. Nevertheless, the skipper suggested the team caught the injury quickly (per ESPN’s Alden González). While the Dodgers have decided that Stewart’s injury necessitates a stint on the IL, the severity of the strain – and therefore his timeline to return – is not yet clear. He will go for further testing tomorrow.
Stewart, now 33, began his career with the Dodgers. They selected him in the 2014 draft, and he struggled his way through parts of four seasons with the big league club from 2016-19. In 36 games (11 starts), the right-hander produced a 5.46 ERA and a 4.93 SIERA. His strikeout rate was low, his walk rate was high, and he gave up 17 home runs in 84 innings pitched, resulting in a 5.70 FIP that was even higher than his ERA. His FanGraphs WAR and Win Probability Added were negative all four years.
After a brief stint with the Blue Jays to close out the 2019 campaign, Stewart did not pitch in the majors for the next three seasons. He spent time in the Cubs and Dodgers organizations in 2020 and ’21, but he did not appear in a game at even the minor league level, due to the cancelled minor league season in 2020 and Tommy John surgery in 2021.
Stewart signed a minor league deal with the Twins in 2022, and the following year, he finally enjoyed his breakout season. Then 31, he pitched 27 2/3 innings in 2023, giving up just two earned runs. Walks continued to be somewhat of an issue, but he struck out 39 of the 109 hitters he faced and gave up only 19 hits (.196 BAA). Unfortunately, elbow troubles popped up again halfway through the year, and he spent most of the final three months of the season on the IL. The year after that, it was shoulder injuries (and eventually surgery) that limited him to just 15 2/3 innings. He posted a bloated 5.17 ERA in that small sample, but his stuff still looked good, and his SIERA was a much more impressive 3.47.
His 2025 season started with yet another injury, but at least it was a hamstring strain rather than an arm issue. It proved to be mild, and Stewart was back on the mound in mid-April. From then on through the trade deadline, he was enjoying the most prolific season of his career. He set a new career high in appearances before the All-Star break, and he was one out shy of surpassing his previous career high in innings when the Twins flipped him to the Dodgers for James Outman on deadline day. While he didn’t look quite as sharp for L.A., perhaps related to his injury, he still entered today ranked among the league’s top 50 relievers (min. 35 IP) in ERA (2.63) and SIERA (3.22). His 27.7% strikeout rate was slightly down from where it was in 2023 and ’24, but his groundball rate was up (37.1%), and, more importantly, his walk rate was all the way down to 8.2%. In other words, the Dodgers will certainly miss his veteran presence on their already injury-plagued pitching staff. He joins fellow relievers Tanner Scott, Kirby Yates, Evan Phillips, Michael Kopech, Michael Grove, and Brusdar Graterol on the IL.
It is perhaps surprising that the Dodgers chose to make a pitcher with such a checkered injury history their primary deadline pickup for the bullpen. Then again, as evidenced by the sheer number of their pitchers who have hit the IL, the Dodgers clearly don’t shy away from injury-prone arms. What’s more, the Dodgers took time to review Stewart’s medicals before finalizing the trade (per Austin Green of The Athletic). That’s standard practice, but Green’s report seems to imply that this was at least a slightly more thorough review than usual.
Regardless, the Dodgers’ surprisingly quiet trade deadline now looks even more disappointing in hindsight. Yet, president of baseball operations Andrew Friedman claims he doesn’t regret his approach. “We don’t live like that,” he told reporters, including Bill Plunkett of the Orange County Register. “There’s deals that we thought made sense for us we pursued hard. It’s not like we had the potential to do a deal where we were like, ‘No’ and now we wish we would have.”
